These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 1360216

  • 1. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone.
    Chu YC, Zong L, Burke GT, Katsoyannis PG.
    J Protein Chem; 1992 Oct; 11(5):571-7. PubMed ID: 1360216
    [Abstract] [Full Text] [Related]

  • 2. Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-tryptophan-A]insulin.
    Ohta N, Burke GT, Katsoyannis PG.
    J Protein Chem; 1988 Feb; 7(1):55-65. PubMed ID: 3076448
    [Abstract] [Full Text] [Related]

  • 3. Nature of the B10 amino acid residue. Requirements for high biological activity of insulin.
    Burke GT, Schwartz G, Katsoyannis PG.
    Int J Pept Protein Res; 1984 Apr; 23(4):394-401. PubMed ID: 6373642
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of placement of tryptophan residues in selected A-chain positions on the biological profile of insulin.
    Chu YC, Burke GT, Ross JB, Katsoyannis PG.
    J Protein Chem; 1993 Aug; 12(4):499-505. PubMed ID: 8251071
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of N-methylation of selected peptide bonds on the biological activity of insulin. [2-N-methylisoleucine-A]insulin and [3-N-methylvaline-A]insulin.
    Ogawa H, Burke GT, Chanley JD, Katsoyannis PG.
    Int J Pept Protein Res; 1987 Oct; 30(4):460-73. PubMed ID: 3323092
    [Abstract] [Full Text] [Related]

  • 8. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L, Barth T, Jirácek J, Barthová J, Zórad S.
    Biochemistry; 2004 Mar 02; 43(8):2323-31. PubMed ID: 14979729
    [Abstract] [Full Text] [Related]

  • 9. Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analogue, [21-asparaginamide-A]insulin.
    Burke GT, Chanley JD, Okada Y, Cosmatos A, Ferderigos N, Katsoyannis PG.
    Biochemistry; 1980 Sep 30; 19(20):4547-56. PubMed ID: 7000179
    [Abstract] [Full Text] [Related]

  • 10. The biological properties of insulins with tyrosine replaced by phenylalanine at positions 14 and 19 of the A chain.
    Cockram CS, Jones RH, Sönksen PH.
    Diabet Med; 1985 Jul 30; 2(4):241-4. PubMed ID: 2951075
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.
    Nakagawa SH, Tager HS.
    J Biol Chem; 1986 Jun 05; 261(16):7332-41. PubMed ID: 3519607
    [Abstract] [Full Text] [Related]

  • 13. Interaction between the A2 and A19 amino acid residues is of critical importance for high biological activity in insulin: [19-leucine-A]insulin.
    Kitagawa K, Ogawa H, Burke GT, Chanley JD, Katsoyannis PG.
    Biochemistry; 1984 Sep 11; 23(19):4444-8. PubMed ID: 6386048
    [Abstract] [Full Text] [Related]

  • 14. Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.
    Linde S, Hansen B, Sonne O, Holst JJ, Gliemann J.
    Diabetes; 1981 Jan 11; 30(1):1-8. PubMed ID: 7014299
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 5-Hydroxytryptophan: an absorption and fluorescence probe which is a conservative replacement for [A14 tyrosine] in insulin.
    Laws WR, Schwartz GP, Rusinova E, Burke GT, Chu YC, Katsoyannis PG, Ross JB.
    J Protein Chem; 1995 May 11; 14(4):225-32. PubMed ID: 7662110
    [Abstract] [Full Text] [Related]

  • 18. Steric requirements at position B12 for high biological activity in insulin.
    Hu SQ, Burke GT, Schwartz GP, Ferderigos N, Ross JB, Katsoyannis PG.
    Biochemistry; 1993 Mar 16; 32(10):2631-5. PubMed ID: 8448120
    [Abstract] [Full Text] [Related]

  • 19. A superactive insulin: [B10-aspartic acid]insulin(human).
    Schwartz GP, Burke GT, Katsoyannis PG.
    Proc Natl Acad Sci U S A; 1987 Sep 16; 84(18):6408-11. PubMed ID: 3306677
    [Abstract] [Full Text] [Related]

  • 20. Superactive insulins.
    Burke GT, Hu SQ, Ohta N, Schwartz GP, Zong L, Katsoyannis PG.
    Biochem Biophys Res Commun; 1990 Dec 31; 173(3):982-7. PubMed ID: 2268358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.